2156885

Rittmaster RS

1990

Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.

2160872

Thompson DL

1990

Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.

2166066

Toscano V

1990

Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.

2174005

Hudson RW

1990

11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism.

2174340

Desjardins GC

1990

Alterations in opioid parameters in the hypothalamus of rats with estradiol-induced polycystic ovarian disease.

2175151

Nagamani M

1990

Specific binding sites for insulin-like growth factor I in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis.

2178292

Maleeva A

1990

[The differential diagnosis of hairy virilism in polycystic ovaries from adrenal cortical hirsutism].

2180477

Fox R

1990

Polycystic ovarian disease (PCOD) and non-insulin-dependent diabetes mellitus (NIDDM)

2185040

Rosenfield RL

1990

Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome.

2185321

Mizunuma H

1990

[Clinical effects of pulsatile LH-RH administration on ovulation induction for women with various type of amenorrhea].

2186596

Insler V

1990

Polycystic ovarian disease: a challenge and controversy.

2191000

Tiitinen A

1990

Plasma androgens and oestradiol during oral glucose tolerance test in patients with polycystic ovaries.

2193664

Erkkola R

1990

Hirsutism: definitions and etiology.

2197574

Piacentino R

1990

[Therapeutic aspects of the polycystic ovary].

2198502

Gonzalez F

1990

Adrenal morphologic considerations in polycystic ovary syndrome.

2201581

Ayala-Ru?z A

1990

[Polycystic ovary syndrome: a hypothalamic or a gonadal anomaly?].

2201617

Shehadeh N

1990

[Hyperinsulinism and hyperandrogenism in polycystic ovarian disease].

2202432

Adams J

1990

Uterine size and endometrial thickness and the significance of cystic ovaries in women with pelvic pain due to congestion.

2205288

Saxton DW

1990

Accuracy of ultrasound measurements of female pelvic organs.

2205423

Graf MJ

1990

The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women.

2208316

Don?t J

1990

[Results of surgical treatment of the polycystic ovary syndrome].

2209217

Rao HL

1990

[Preliminary study on 4 indices of basal body temperature in the evaluation of luteal phase insufficiency after clomiphene treatment].

2209878

Lissak A

1990

The effect of metoclopramide on ovarian responsiveness to gonadotropin administration in patients with severe polycystic ovarian syndrome.

2209879

Bider D

1990

Aromatase activity of human granulosa cells in patients with polycystic ovaries treated with dexamethasone.

2217009

Conway GS

1990

Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.

2220936

Nestler JE

1990

Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women.

2221813

Goh HH

1990

The gonadotrophin surge in humans: its mechanism and role in ovulatory function--a review.

2224213

Conway GS

1990

Hirsutism.

2225492

Hague WM

1990

The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives.

2225591

Barbieri RL

1990

Hyperandrogenic disorders.

2225592

Cheung AP

1990

Polycystic ovary syndrome.

2226905

Kiriushchenkov AP

1990

[The polycystic ovary syndrome].

2227610

Takahashi K

1990

Transvaginal ultrasound is an effective method for screening in polycystic ovarian disease: preliminary study.

2228390

Segal KR

1990

Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome.

2229271

Martin K

1990

Clinical review 15: Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone.

2230412

Sugiyama Y

1990

[The role of insulin in reproductive endocrinology and perinatal medicine].

2235937

Starkova NT

1990

[The hormonal-metabolic correlations in the generalized lipodystrophy syndrome].

2237076

Richard EK

1990

[Endometrial adenocarcinoma and polycystic ovary syndrome].

2240131

Schriock ED

1990

Practical aspects of pulsatile gonadotropin-releasing hormone administration.

2253411

Vaughan Williams CA

1990

Ovarian electrocautery or hormone therapy in the treatment of polycystic ovary syndrome.

2256513

Wild RA

1990

Evidence of heterogeneous mechanisms in lipoprotein lipid alterations in hyperandrogenic women.

2259543

Rosenfield RL

1990

Hyperandrogenism in peripubertal girls.

2259909

Schurz B

1990

[Gynecologic Doppler ultrasonography].

2262393

Francis GL

1990

Preliminary results suggesting exaggerated ovarian androgen production early in the course of polycystic ovary syndrome.

2266154

Dor J

1990

The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility.

2269012

Shelley DR

1990

Polycystic ovary syndrome.

2278313

Soboleva EL

1990

[The therapeutic effect of parlodel in the polycystic ovary syndrome].

2278320

Ataniiazova OA

1990

[The current concept of the pathogenesis, diagnosis and treatment of the polycystic ovary syndrome].

2282743

Shoham Z

1990

Induction of ovulation with pulsatile GnRH.

2282744

Hamilton-Fairley D

1990

Common problems in induction of ovulation.

2284980

Prelevi? GM

1990

Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.

2316374

Sageshima M

1990

Massive ovarian edema associated with polycystic ovary.

2323428

Alieva EA

1990

[The polycystic ovary syndrome].

2325031

Singh KB

1990

Ultrastructural basis for continued steroidogenesis in the rat polycystic ovary.

2327604

Convery M

1990

Remission of the polycystic ovarian condition (PCO) in the rat following hemiovariectomy.

2332069

Awadalla SG

1990

Gedankenexperiments.

2332079

Aisaka K

1990

[Comprehensive approach to clinical background and effect of bromocriptine administration in patients with endocrinological polycystic ovarian disease].

2340260

Burrell LM

1990

Autoimmune ovarian failure with elevated serum levels of luteinizing hormone and enlarged ovaries. Case report.

2347090

Eden JA

1990

Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles.

2347091

Hague WM

1990

HLA associations in patients with polycystic ovaries and in patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency.

2358090

Netter A

1990

Polycystic ovary syndrome.

2362450

Montalto J

1990

Serum 5-androstene-3 beta,17 beta-diol sulphate and 5 alpha-androstane-3 alpha,17 beta-diol sulphate in hirsute females with polycystic ovarian disease.

2367912

Makeev SA

1990

[The effect of ultraviolet irradiation of the blood on various hormonal indicators in women with sclerocystic ovaries].

2378402

Volobuev AI

1990

[Breast diseases in patients with hyperandrogenism].

2400064

Ivanov L

1990

[Term pregnancy in uterine fibroelastosis and cystic degeneration of the ovaries].

2400360

McKenna KM

1990

Hirsutism in a gynaecological context.

2401719

Kazer RR

1990

An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome.

2407584

Buffington CK

1990

Sensitivity of pyruvate dehydrogenase to insulin in activated T lymphocytes. Lack of responsiveness to insulin in patients with polycystic ovarian disease and diabetes.

2434364

Rezai P

1987

Free alpha-subunit response to gonadotropin-releasing hormone in women with polycystic ovaries.

2460770

Moller DE

1988

Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance).

2465307

Suikkari AM

1989

Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease.

2471710

Spinder T

1989

The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.

2485372

Fuhrer J

1989

[Effect of bromocryptin in polycystic ovary syndrome].

2485729

Bolanowski M

1989

Induction of ovulation by pulsatile LH-RH administration in polycystic ovarian syndrome.

2490173

Porcile A

1989

[Treatment of anovulation in polycystic ovary syndrome with clomiphene citrate in 10-day cycles].

2491993

Burger CW

1989

Ovulation induction with pulsatile luteinizing hormone-releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: endocrine results.

2491994

Polson DW

1989

Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.

2492145

Remorgida V

1989

Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives.

2492787

Barnes R

1989

The polycystic ovary syndrome: pathogenesis and treatment.

2493284

Turner E

1989

Luteinising hormone in polycystic ovary syndrome.

2493402

Nakamura Y

1989

Clinical experience in the induction of ovulation and pregnancy with pulsatile subcutaneous administration of human menopausal gonadotropin: a low incidence of multiple pregnancy.

2496866

Homburg R

1989

One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation.

2497131

Quartero HW

1989

Ovulation induction in polycystic ovarian disease by pure FSH (Metrodin). A comparison between chronic low-dose pulsatile administration and i.m. injections.

2497244

Marut EL

1989

The polycystic ovary syndrome.

2497247

Dodson WC

1989

Role of gonadotropin releasing hormone agonists in ovulation induction.

2497249

Caldwell BV

1989

Monitoring gonadotropin therapy.

2498378

Nestler JE

1989

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.

2499904

Spinder T

1989

Pulsatile luteinizing hormone release and ovarian steroid levels in female-to-male transsexuals compared to heterosexual women.

2501103

Furudate S

1989

PMSG-induced persistent estrus in rats as a model for polycystic ovary disease: characteristics and restoration to the normal cycle.

2501207

Anapliotou ML

1989

Paradoxical growth hormone response following thyroid-stimulating hormone administration in the polycystic ovary syndrome.

2501338

Faure N

1989

Assessment of ovaries by magnetic resonance imaging in patients presenting with polycystic ovarian syndrome.

2502437

Anderson RE

1989

A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome.

2503254

Yu J

1989

[Changes in serum FSH, LH and ovarian follicular growth during electroacupuncture for induction of ovulation].

2504852

Tanaka Y

1989

[Polycystic ovary syndrome in a patient undergoing maintenance hemodialysis].

2505956

Eden JA

1989

Is the polycystic ovary a cause of infertility in the ovulatory woman?

2506216

Filicori M

1989

The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.

2507714

Uemura T

1989

[Comparison between purified FSH and hMG for induction of ovulation in women with PCO syndrome].

2508354

Klingm?ller V

1989

[Ultrasonic evaluation of multicystic ovaries in childhood].

2508581

Alexander H

1989

[Spontaneous endogenous LH increase in the stimulated cycle].

2508743

Polson DW

1989

Low-dose follicle-stimulating hormone in the treatment of polycystic ovary syndrome: a comparison of pulsatile subcutaneous with daily intramuscular therapy.